hydroxychloroquine and semaglutide Hydroxychloroquine: The Controversial Use | Trending FDA Authorizes Anti-Malarial Drugs Chloroquine

Foundayo (Orforglipron) : An innovative oral GLP-1 medication that offers dosing flexibility without dietary constraints

Your Health History Matters: Sharing your complete medical history with your provider is essential for your safety and treatment plan optimization

Patients should be educated about warning signs that require immediate medical attention, and provided with clear written information about both medications, including how to take them correctly and what to expect

As of July 2026, it is an investigational triple-agonist (GIP/GLP-1/glucagon) developed by Eli Lilly and is in Phase 3 clinical trials for obesity